Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Telomir Pharmaceuticals Inc. Common Stock
TELO | US
1.40
USD0.02
1.45%
TELO | US
Loading StockChartView...
About Telomir Pharmaceuticals Inc. Common Stock
Sector
US
Industry
US
Earnings date
30/06/2024
As of date
24/04/2026
Close
1.40
Open
1.39
High
1.44
Low
1.33
View Less
TELO | US
Risk
80.3
Sharpe
-0.42
Luna's Score
43/100
Recommendation
Sell
Luna says (TELO | US)
What's Working
What's not Working
Microcap (<300M USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
63.6%1 month
80.3%3 months
68.5%6 months
61.8%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
114.66
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-
MarketCap
53.54M
MarketCap(USD)
53.54M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-686.91
Short ratio
1.51
Short perc.
0.97
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.35
Range1M
0.39
Range3M
0.44
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.68
Price X volume
82.76K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | - | - | - |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | - | - |
| Price to Book | 114.66 | - | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 68.54 | - | - |
| Debt to Equity | - | - | - |
| Debt to Assets | - | - | - |
| Market Cap | 53.54M | - | - |
